Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.

Source:http://linkedlifedata.com/resource/pubmed/id/21848202

Download in:

View as

General Info

PMID
21848202